PCRX Share Price

Open 47.70 Change Price %
High 48.80 1 Day 1.05 2.20
Low 47.70 1 Week -0.50 -1.02
Close 48.70 1 Month 1.25 2.63
Volume 633870 1 Year 11.04 29.31
52 Week High 58.95
52 Week Low 29.95
PCRX Important Levels
Resistance 2 49.72
Resistance 1 49.30
Pivot 48.40
Support 1 48.10
Support 2 47.68
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
ASTI 0.00 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
More..
NASDAQ USA Top Gainers Stocks
TOPS 0.44 69.23%
SCHS 0.05 66.67%
ELTK 0.95 53.23%
LOCM 0.09 50.00%
SGMS 34.15 27.19%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
MTSL 0.64 20.75%
WBMD 66.10 19.77%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
CYTX 0.48 -56.76%
AMCF 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX)

PCRX Technical Analysis 4
As on 24th Jul 2017 PCRX Share Price closed @ 48.70 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 41.31 & Buy for SHORT-TERM with Stoploss of 47.18 we also expect STOCK to react on Following IMPORTANT LEVELS.
PCRX Target for July
1st Target up-side 51.62
2nd Target up-side 54.37
3rd Target up-side 57.12
1st Target down-side 43.78
2nd Target down-side 41.03
3rd Target down-side 38.28
PCRX Other Details
Segment EQ
Market Capital 512069248.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.pacira.com
PCRX Address
PCRX
5 Sylvan Way
Suite 100
Parsippany, NJ 07054
United States
Phone: 973-254-3560
PCRX Latest News
Interactive Technical Analysis Chart Pacira Pharmaceuticals, Inc. ( PCRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pacira Pharmaceuticals, Inc.
PCRX Business Profile
Pacira Pharmaceuticals, Inc. is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control. Its products include EXPAREL (bupivacaine liposome injectable suspension) is a liposome injection of bupivacaine, an amide-type local anesthetic; DepoCyt(e) (cytarabine liposome injection) is a sustained-release liposomal formulation of the chemotherapeutic agent cytarabine; and DepoDur (morphine sulfate extended-release liposome injection) is an extended-release, injectable formulation of morphine.